Virtu Financial’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
Other funds holding URGN
KCM
ACA
OM
Virtu Financial's URGN Position: Q3 2026 in Review
Virtu Financial opened a new position in UroGen Pharma (URGN) in Q3 2026: 16,363 shares worth $665K. The stake represents 0.02% of the portfolio and ranks #443 among its holdings. This is a return to the name: Virtu Financial previously reported a position in URGN as recently as Q2 2025.
Virtu Financial first reported a position in URGN in Q1 2018 and has held it in 4 quarters since. The position peaked at $671K in Q2 2018. 221 funds tracked by Wall St. Rank hold URGN as of Q3 2026.
- Virtu Financial held 16,363 shares of UroGen Pharma worth $665K as of Q3 2026.
- UroGen Pharma was a new Virtu Financial position in Q3 2026.
- UroGen Pharma made up 0.02% of Virtu Financial's portfolio in Q3 2026, its #443 holding.
- Virtu Financial first reported a position in UroGen Pharma in Q1 2018 and has held it in 4 quarters since.
- Virtu Financial's UroGen Pharma position peaked at $671K in Q2 2018.
- 221 funds tracked by Wall St. Rank held UroGen Pharma as of Q3 2026.
Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.